Meloche argues retirement income and decumulation solutions need scale, sponsor readiness, and advisor education before Canadian DC plans can adopt them
Merck's Lipfendra wins FDA approval as the first oral PCSK9 inhibitor, and Canadian plan sponsors have reason to watch closely
Meloche argues retirement income and decumulation solutions need scale, sponsor readiness, and advisor education before Canadian DC plans can adopt them
China allocation debate heats up among emerging market fund managers
Emerging markets equities are back on the radar for Canadian institutions seeking growth, diversification and AI‑linked opportunities. Hear Ninety One’s Varun Laijawalla, with moderator Samantha Cleyn, share practical insights on positioning EM in 2026.
This session brings together experts from Beneva to share the latest insights on managing cost of neurological conditions in the workforce. Watch on-demand today!
Join BMO Global Asset Management’s Responsible Investing team for a webinar on ESG-focused strategies to manage financial risks and opportunities. Learn how responsible investing can support Indigenous communities!
Join us for an insightful webinar exploring governance strategies, the growing role of delegation, and best practices to help CAP plan sponsors navigate challenges and position their plans for long-term success.
